Literature DB >> 9407054

Resistance to endotoxic shock in phospholipase A2 receptor-deficient mice.

K Hanasaki1, Y Yokota, J Ishizaki, T Itoh, H Arita.   

Abstract

Mammals possess various types of secretory phospholipase A2, which differ in the primary structure and tissue distribution. The phosholipase A2 receptor (PLA2R) recognizes group IB phospholipase A2 (PLA2-IB) and mediates the PLA2-IB-induced biological responses in non-digestive organs, including eicosanoid production and contraction of airway smooth muscles. In this study, we generated PLA2R-deficient mice to define its biological roles further. These mice are viable, fertile, and without evident histopathological abnormalities. There was no difference in the clearance of circulating PLA2-IB between wild-type and mutant mice. After challenge with bacterial lipopolysaccharide (LPS), PLA2R-deficient mice exhibited longer survival than wild-type mice. The mutant mice were also resistant to lethal effects of exogenous PLA2-IB after sensitization with sublethal dose of LPS. The plasma levels of tumor necrosis factor-alpha and interleukin-1beta elevated after LPS treatment were significantly reduced in mutant mice compared with wild-type mice. These findings suggest a potential role of PLA2R in the progression of endotoxic shock.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9407054     DOI: 10.1074/jbc.272.52.32792

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  19 in total

1.  Complex determinants in specific members of the mannose receptor family govern collagen endocytosis.

Authors:  Henrik J Jürgensen; Kristina Johansson; Daniel H Madsen; Astrid Porse; Maria C Melander; Kristine R Sørensen; Christoffer Nielsen; Thomas H Bugge; Niels Behrendt; Lars H Engelholm
Journal:  J Biol Chem       Date:  2014-02-05       Impact factor: 5.157

2.  Purification, characterization, and molecular cloning of group I phospholipases A2 from the gills of the red sea bream, Pagrus major.

Authors:  N Iijima; S Uchiyama; Y Fujikawa; M Esaka
Journal:  Lipids       Date:  2000-12       Impact factor: 1.880

Review 3.  Whole exome sequencing in a patient with uniparental disomy of chromosome 2 and a complex phenotype.

Authors:  H Carmichael; Y Shen; T T Nguyen; J N Hirschhorn; A Dauber
Journal:  Clin Genet       Date:  2012-12-20       Impact factor: 4.438

4.  A new era of secreted phospholipase A₂.

Authors:  Makoto Murakami; Hiroyasu Sato; Yoshimi Miki; Kei Yamamoto; Yoshitaka Taketomi
Journal:  J Lipid Res       Date:  2015-03-24       Impact factor: 5.922

5.  Secreted phospholipases A(2), a new class of HIV inhibitors that block virus entry into host cells.

Authors:  D Fenard; G Lambeau; E Valentin; J C Lefebvre; M Lazdunski; A Doglio
Journal:  J Clin Invest       Date:  1999-09       Impact factor: 14.808

6.  Prediction of regulatory networks in mouse abdominal wall.

Authors:  Diana Eng; Adam Campbell; Traci Hilton; Mark Leid; Michael K Gross; Chrissa Kioussi
Journal:  Gene       Date:  2010-08-24       Impact factor: 3.688

7.  Inducible expression of the kinin B1 receptor in the endotoxemic heart: mechanisms of des-Arg9bradykinin-induced coronary vasodilation.

Authors:  P G McLean; M Perretti; A Ahluwalia
Journal:  Br J Pharmacol       Date:  1999-09       Impact factor: 8.739

Review 8.  Role of secretory phospholipase a(2) in CNS inflammation: implications in traumatic spinal cord injury.

Authors:  W Lee Titsworth; Nai-Kui Liu; Xiao-Ming Xu
Journal:  CNS Neurol Disord Drug Targets       Date:  2008-06       Impact factor: 4.388

9.  Analysis of several PLA2 mRNA in human meningiomas.

Authors:  Yves Denizot; Rafael De Armas; Karine Durand; Sandrine Robert; Jean-Jacques Moreau; François Caire; Nicolas Weinbreck; François Labrousse
Journal:  Mediators Inflamm       Date:  2010-03-21       Impact factor: 4.711

10.  Aberrant methylation of the M-type phospholipase A(2) receptor gene in leukemic cells.

Authors:  Mario Menschikowski; Uwe Platzbecker; Albert Hagelgans; Margot Vogel; Christian Thiede; Claudia Schönefeldt; Renate Lehnert; Graeme Eisenhofer; Gabriele Siegert
Journal:  BMC Cancer       Date:  2012-12-05       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.